We are live on ! Find out more
ORIA

Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA

Delisted

ORIA was delisted on the 28th of April, 2023.

Back to rankings

52 hedge funds and large institutions have $142M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

10% more capital invested

Capital invested by funds: $130M → $142M (+$12.6M)

8% more funds holding

Funds holding: 48 → 52 (+4)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

Holders
52
Holders Change
+4
Holders Change %
+8.33%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
9
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$4.83M
2
GCL
Glazer Capital LLC
New York
+$3.71M
3
Calamos Advisors
Calamos Advisors
Illinois
+$3.68M
4
AC
Aristeia Capital
Connecticut
+$2.45M
5
Millennium Management
Millennium Management
New York
+$1.19M

Top Sellers

Rank Fund Capital Flow
1
KC
Kepos Capital
New York
-$4.87M
2
PC
Periscope Capital
Ontario, Canada
-$1.26M
3
ACA
Arena Capital Advisors
California
-$1.08M
4
HighTower Advisors
HighTower Advisors
Illinois
-$706K
5
BCM
Basso Capital Management
Connecticut
-$488K
Name Holding Trade Value Shares
Change 		Change in
Stake
FTCM
26
First Trust Capital Management
Illinois
$1.72M +$59 +6 +0%
WRBC
27
W.R. Berkley Corp
Connecticut
$1.7M – – –
RCM
28
Rivernorth Capital Management
Florida
$1.7M – – –
SCM
29
Segantii Capital Management
Hong Kong
$1.48M – – –
PMAM
30
Picton Mahoney Asset Management
Ontario, Canada
$1.48M – – –
ACA
31
Arena Capital Advisors
California
$1.39M -$1.08M -109,600 -44%
CCM
32
Context Capital Management
California
$1.04M – – –
LP
33
LMR Partners
United Kingdom
$1.03M +$1.03M +105,100 New
CH
34
CVI Holdings
Delaware
$1M – – –
WAM
35
Weiss Asset Management
Massachusetts
$996K +$991K +101,005 New
DCM
36
Dupont Capital Management
Delaware
$986K – – –
SSA
37
Schonfeld Strategic Advisors
New York
$959K +$466K +47,475 +95%
DCM
38
DG Capital Management
New York
$933K -$324K -33,036 -26%
AFM
39
Anson Funds Management
Texas
$738K – – –
WA
40
Whitebox Advisors
Minnesota
$738K – – –
COPPSERS
41
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$492K – – –
ETH
42
Exos TFP Holdings
New York
$425K +$423K +43,165 New
LA
43
Linden Advisors
New York
$411K – – –
Bank of Nova Scotia
44
Bank of Nova Scotia
Ontario, Canada
$394K – – –
PAMP
45
Polar Asset Management Partners
Ontario, Canada
$265K – – –
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$249K +$248K +25,301 New
HF
47
HRT Financial
New York
$195K -$3.47K -354 -2%
VF
48
Virtu Financial
New York
$114K +$113K +11,549 New
CC
49
Centiva Capital
New York
$104K -$2.94K -300 -3%
WAM
50
Wolverine Asset Management
Illinois
$23K -$74.9K -7,631 -76%
1
2
3

ORIA Hedge Fund Activity: Q3 2022 in Review

52 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) for Q3 2022, worth a combined $142M — up 9.7% from $130M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ORIA positions and 3 closed out — a net gain of 5 holders — while 8 added to existing stakes and 9 trimmed.

The largest buyer was Magnetar Financial, adding an estimated $4.83M. The largest seller was Kepos Capital, exiting entirely with an estimated $4.87M sold.

  • 52 institutional investors held Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) as of Q3 2022, up from 48 in Q2 2022.
  • Funds reported $142M of Orion Biotech Opportunities Corp. Class A Ordinary Share stock for Q3 2022, up 9.7% quarter-over-quarter.
  • 8 funds opened new Orion Biotech Opportunities Corp. Class A Ordinary Share positions in Q3 2022 and 3 closed out, a net change of +5 holders.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share buyer in Q3 2022 was Magnetar Financial, an estimated $4.83M added.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share seller in Q3 2022 was Kepos Capital, an estimated $4.87M sold.

Based on aggregated 13F filings for Q3 2022.